Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Fish Biol ; 92(6): 1915-1928, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29624674

RESUMO

Membranous organelles, acid glycoconjugates and lipids were characterized in the digestive tract mucosa of Hemisorubim platyrhynchos by cytochemistry techniques. Two types of mucous-secreting cells were observed in the digestive tract epithelium: goblet cells in the oesophagus and intestine and epithelial cells in the stomach. These cells had a Golgi apparatus more developed than the other cell types. The cytochemical analysis revealed that secretory granules are reactive to acid glycoconjugates, varying in reaction intensity according to the region of the digestive tract. Acid glycoconjugate reactions were also observed in oesophageal epithelial cell microridges and in enterocyte microvilli. In the digestive tract, acid glycoconjugates act to protect the epithelial surface, increasing mucous viscosity, which facilitates the passage of food, prevents the binding of parasites and facilitates their removal. Through lipid staining, a coated membrane was observed around each secretory granule of the oesophageal and intestinal goblet cells, while gastric epithelial cells granules were fully reactive. Oxynticopeptic cells of the gastric glands showed lipid droplets in the cytoplasm and also in the mitochondrial matrix, which act as an energy reserve for these cells that have a high energy demand. Enterocytes showed a well-developed smooth endoplasmic reticulum, especially in the apical region of the cell, being related to absorption and resynthesis of lipids.


Assuntos
Peixes-Gato/anatomia & histologia , Mucosa Esofágica/ultraestrutura , Mucosa Gástrica/ultraestrutura , Mucosa Intestinal/ultraestrutura , Animais , Células Epiteliais , Epitélio , Esôfago , Trato Gastrointestinal , Histocitoquímica , Intestinos , Muco , Estômago
2.
BJOG ; 123(3): 427-36, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26259689

RESUMO

OBJECTIVE: To generate a global reference for caesarean section (CS) rates at health facilities. DESIGN: Cross-sectional study. SETTING: Health facilities from 43 countries. POPULATION/SAMPLE: Thirty eight thousand three hundred and twenty-four women giving birth from 22 countries for model building and 10,045,875 women giving birth from 43 countries for model testing. METHODS: We hypothesised that mathematical models could determine the relationship between clinical-obstetric characteristics and CS. These models generated probabilities of CS that could be compared with the observed CS rates. We devised a three-step approach to generate the global benchmark of CS rates at health facilities: creation of a multi-country reference population, building mathematical models, and testing these models. MAIN OUTCOME MEASURES: Area under the ROC curves, diagnostic odds ratio, expected CS rate, observed CS rate. RESULTS: According to the different versions of the model, areas under the ROC curves suggested a good discriminatory capacity of C-Model, with summary estimates ranging from 0.832 to 0.844. The C-Model was able to generate expected CS rates adjusted for the case-mix of the obstetric population. We have also prepared an e-calculator to facilitate use of C-Model (www.who.int/reproductivehealth/publications/maternal_perinatal_health/c-model/en/). CONCLUSIONS: This article describes the development of a global reference for CS rates. Based on maternal characteristics, this tool was able to generate an individualised expected CS rate for health facilities or groups of health facilities. With C-Model, obstetric teams, health system managers, health facilities, health insurance companies, and governments can produce a customised reference CS rate for assessing use (and overuse) of CS. TWEETABLE ABSTRACT: The C-Model provides a customized benchmark for caesarean section rates in health facilities and systems.


Assuntos
Cesárea/estatística & dados numéricos , Modelos Estatísticos , Adulto , Estudos Transversais , Feminino , Humanos , Internacionalidade , Gravidez , Valores de Referência
3.
BJOG ; 121 Suppl 1: 110-8, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24641541

RESUMO

OBJECTIVE: To develop and test markers of neonatal severe morbidity for the identification of neonatal near-miss cases. DESIGN: This is a database analysis of two World Health Organization cross-sectional studies: the Global Survey on Maternal and Perinatal Health (WHOGS) and the Multicountry Survey on Maternal and Newborn Health (WHOMCS). SETTING: The WHOGS was performed in 373 health facilities in 24 countries (2004-2008). The WHOMCS was conducted in 359 health facilities in 29 countries (2010-2011). POPULATION: Data were collected from hospital records of all women admitted for delivery and their respective neonates. METHODS: Pragmatic markers (birthweight <1750 g, Apgar score at 5 minutes <7, and gestational age <33 weeks) were developed with WHOGS data and validated with WHOMCS data. The diagnostic accuracy of neonatal characteristics and management markers of severity was determined in the WHOMCS. RESULTS: This analysis included 290 610 liveborn neonates from WHOGS and 310 436 liveborn neonates from WHOMCS. The diagnostic accuracy of pragmatic and management markers of severity for identifying early neonatal deaths was very high: sensitivity, 92.8% (95% CI 91.8-93.7%); specificity, 92.7% (95% CI 92.6-92.8%); positive likelihood ratio, 12.7 (95% CI 12.5-12.9); negative likelihood ratio, 0.08 (95% CI 0.07-0.09); diagnostic odds ratio, 163.4 (95% CI 141.6-188.4). A positive association was found between the frequency of neonatal near-miss cases and Human Development Index. CONCLUSION: Newborn infants presenting selected markers of severity and surviving the first neonatal week could be considered as neonatal near-miss cases. This definition and criteria may be seen as a basis for future applications of the near-miss concept in neonatal health. These tools can be used to inform policy makers on how best to apply scarce resources for improving the quality of care and reducing neonatal mortality.


Assuntos
Mortalidade Infantil , Nascido Vivo/epidemiologia , Serviços de Saúde Materna/estatística & dados numéricos , Adolescente , Adulto , África/epidemiologia , Índice de Apgar , Ásia/epidemiologia , Biomarcadores , Estudos Transversais , Feminino , Idade Gestacional , Pesquisas sobre Atenção à Saúde , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , América Latina/epidemiologia , Oriente Médio/epidemiologia , Valor Preditivo dos Testes , Gravidez , Reprodutibilidade dos Testes , Organização Mundial da Saúde , Adulto Jovem
4.
Clin Transl Oncol ; 16(3): 330-5, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23860726

RESUMO

PURPOSE: Regulatory T cells (Tregs) play a role in the immunosuppressive state in pancreatic cancer patients. We aimed to evaluate the changes of immune cells population including Tregs caused by gemcitabine (GEM)-based chemotherapy. METHODS: Fifty-three patients with pancreatic cancer were enrolled in this study, of which 32 received GEM- based chemotherapy. Blood samples were collected before and at least 2 weeks after the last dose of chemotherapy. The peripheral blood mononuclear cells (PBMCs) were subjected to flow cytometry analysis after labeling with anti-CD4, anti-CD25, and anti-Foxp3 antibodies. Other lymphocytes and NK cell markers were also measured. The proliferative capacity of PBMCs stimulated with anti-CD3 was analyzed using H(3) thymidine. RESULTS: The percentage and number of Tregs were significantly decreased after chemotherapy (p = 0.032, p = 0.003, respectively). The other immune cells and the proliferative capacity did not change. CONCLUSION: This study showed that GEM-based chemotherapy produced an immunomodulatory effect via the depletion of Tregs.


Assuntos
Antimetabólitos Antineoplásicos/uso terapêutico , Proliferação de Células/efeitos dos fármacos , Desoxicitidina/análogos & derivados , Neoplasias Pancreáticas/tratamento farmacológico , Neoplasias Pancreáticas/imunologia , Linfócitos T Reguladores/efeitos dos fármacos , Adulto , Idoso , Idoso de 80 Anos ou mais , Desoxicitidina/uso terapêutico , Feminino , Citometria de Fluxo , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Pancreáticas/sangue , Gencitabina
5.
Curr Top Med Chem ; 12(19): 2059-69, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23167795

RESUMO

Type 2 diabetes mellitus is characterized by disruption in glycemic homeostasis, involving impaired insulin-induced glucose disposal. For that, reduced glucose transporter GLUT4, encoded by Slc2a4 gene, plays a fundamental role. Conversely, increase in Slc2a4/GLUT4 expression improves glycemic homeostasis. Recent studies have proposed that estradiol is able to modulate Slc2a4 expression, according to distinct effects upon estrogen receptors ESR1/ESR2. We hypothesize that ESR1-agonist effect could stimulate Slc2a4 expression; thus, increasing cellular glucose disposal, which could be beneficial to glycemic control. Differentiated 3T3-L1 adipocytes were treated (24 hours) with selective ESR1- agonist PPT 1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole, selective ESR1-antagonist MPP 1,3-Bis(4- hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride, and selective ESR2 agonist DPN 2,3-bis(4-Hydroxyphenyl)-propionitrile, with/without 17ß-estradiol (E2). We analyzed Slc2a4 mRNA (real time PCR) and GLUT4 protein (Western blotting) expression, transcriptional activity of the Slc2a4 repressor Nuclear Factor- κB (NF-κB) (electrophoretic mobility shift assay), and cellular glucose disposal (2-deoxi-D-[(3)H]glucose uptake, 2-DG). ESR1-agonist PPT enhanced Slc2a4/GLUT4 expression (~30%) in the absence or presence of 0.1 and 10 nmol/L E2, and decreased the NF-κB binding activity (~50%). Conversely, ESR1-antagonist MPP, together with E2, decreased Slc2a4/GLUT4 expression (20-40%) and increased NF-κB binding activity (~30%). Furthermore, treatment with ESR2- agonist DPN decreased Slc2a4/GLUT4 expression (20-50%). 2-DG uptake was modulated in parallel to that observed in GLUT4 protein. The present results reveal that ESR1 activity enhances, whereas ESR2 activity represses, Slc2a4/GLUT4 expression. These effects are partially mediated by NF-κB, and allow parallel changes in adipocyte glucose disposal. Furthermore, the data provide evidences that ESR1-agonist PPT, as a Slc2a4/GLUT4 enhancer, can be a promising coadjuvant drug for diabetes mellitus therapy.


Assuntos
Adipócitos/efeitos dos fármacos , Receptor alfa de Estrogênio/agonistas , Transportador de Glucose Tipo 4/genética , Glucose/metabolismo , Insulina/farmacologia , Fenóis/farmacologia , Pirazóis/farmacologia , Células 3T3-L1 , Adipócitos/metabolismo , Animais , Sequência de Bases , Western Blotting , Primers do DNA , Ensaio de Desvio de Mobilidade Eletroforética , Camundongos , Reação em Cadeia da Polimerase , RNA Mensageiro/genética
6.
Rhinology ; 50(2): 129-38, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22616073

RESUMO

INTRODUCTION: Studies designed to investigate chronic rhinosinusitis (CRS) epidemiology play an important role to assess population`s distribution and risk factors to result in the development and promotion of public health policies. METHOD: This study design is a survey carried out with a complex two-stage cluster sampling plan. Personal interviews were carried out with 2,003 individuals. The questionnaire included the epidemiological criteria for CRS. Demographic data, history of physician-diagnosed respiratory diseases (asthma, sinusitis, rhinitis), smoking, family income, educational attainment, and household characteristics were also evaluated. RESULTS: The overall response rate was 93.9% of the households. Mean age was 39.8 +- 21 years; 45.33% were male. The overall prevalence of CRS in the city of Sao Paulo was 5.51%. We found a significant association between diagnosis of CRS and diagnosis of asthma and CRS and diagnosis of rhinitis and a significant association between presence of CRS and belonging to the low-income subgroup. CONCLUSION: The municipality of Sao Paulo has an urban population of 11 million. According to the present study, the prevalence of CRS is 5.51%, which represents more than 500,000 individuals affected by this condition in the city.


Assuntos
Rinite/epidemiologia , Sinusite/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Brasil/epidemiologia , Criança , Doença Crônica , Análise por Conglomerados , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fumar/epidemiologia , População Urbana , Adulto Jovem
7.
Braz J Med Biol Res ; 43(11): 1019-26, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21049241

RESUMO

Glucose enters eukaryotic cells via two types of membrane-associated carrier proteins, the Na(+)/glucose cotransporters (SGLT) and the facilitative glucose transporters (GLUT). The SGLT family consists of six members. Among them, the SGLT1 and SGLT2 proteins, encoded by the solute carrier genes SLC5A1 and SLC5A2, respectively, are believed to be the most important ones and have been extensively explored in studies focusing on glucose fluxes under both physiological and pathological conditions. This review considers the regulation of the expression of the SGLT promoted by protein kinases and transcription factors, as well as the alterations determined by diets of different compositions and by pathologies such as diabetes. It also considers congenital defects of sugar metabolism caused by aberrant expression of the SGLT1 in glucose-galactose malabsorption and the SGLT2 in familial renal glycosuria. Finally, it covers some pharmacological compounds that are being currently studied focusing on the interest of controlling glycemia by antagonizing SGLT in renal and intestinal tissues.


Assuntos
Regulação da Expressão Gênica/genética , Transdução de Sinais/genética , Transportador 1 de Glucose-Sódio/genética , Transportador 2 de Glucose-Sódio/genética , Transcrição Gênica/genética , Animais , Diabetes Mellitus/genética , Diabetes Mellitus/fisiopatologia , Regulação da Expressão Gênica/fisiologia , Humanos , Transdução de Sinais/fisiologia , Transportador 1 de Glucose-Sódio/fisiologia , Transportador 2 de Glucose-Sódio/fisiologia , Transcrição Gênica/fisiologia
8.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;43(11): 1019-1026, Nov. 2010. ilus
Artigo em Inglês | LILACS | ID: lil-564139

RESUMO

Glucose enters eukaryotic cells via two types of membrane-associated carrier proteins, the Na+/glucose cotransporters (SGLT) and the facilitative glucose transporters (GLUT). The SGLT family consists of six members. Among them, the SGLT1 and SGLT2 proteins, encoded by the solute carrier genes SLC5A1 and SLC5A2, respectively, are believed to be the most important ones and have been extensively explored in studies focusing on glucose fluxes under both physiological and pathological conditions. This review considers the regulation of the expression of the SGLT promoted by protein kinases and transcription factors, as well as the alterations determined by diets of different compositions and by pathologies such as diabetes. It also considers congenital defects of sugar metabolism caused by aberrant expression of the SGLT1 in glucose-galactose malabsorption and the SGLT2 in familial renal glycosuria. Finally, it covers some pharmacological compounds that are being currently studied focusing on the interest of controlling glycemia by antagonizing SGLT in renal and intestinal tissues.


Assuntos
Animais , Humanos , Regulação da Expressão Gênica/genética , Transdução de Sinais/genética , Transportador 1 de Glucose-Sódio/genética , /genética , Transcrição Gênica/genética , Diabetes Mellitus/genética , Diabetes Mellitus/fisiopatologia , Regulação da Expressão Gênica/fisiologia , Transdução de Sinais/fisiologia , Transportador 1 de Glucose-Sódio/fisiologia , /fisiologia , Transcrição Gênica/fisiologia
9.
Mol Cell Endocrinol ; 305(1-2): 63-70, 2009 Jun 16.
Artigo em Inglês | MEDLINE | ID: mdl-19433262

RESUMO

We hypothesize that, in kidney of diabetic rats, hepatocyte nuclear factors (HNF-1alpha and HNF-3beta) play a critical role in the overexpression of solute carrier 2A2 (SLC2A2) gene. Diabetic rats submitted or not to rapid (up to 12h) and short-term (1, 4 and 6 days) insulin treatment were investigated. Twofold increase in GLUT2 mRNA was observed in diabetic, accompanied by significant increases in HNF-1alpha and HNF-3beta expression and binding activity. Additional 2-fold increase in GLUT2 mRNA and HNF-3beta expression/activity was observed in 12-h insulin-treated rats. Six-day insulin treatment decreased GLUT2 mRNA and HNF-1alpha expression and activity to levels of non-diabetic rats, whereas HNF-3beta decreased to levels of non-insulin-treated diabetic rats. Our results provide evidence for a link between the overexpression of SLC2A2 gene and the transcriptional activity of HNF-1alpha and HNF-3beta in kidney of diabetic rats. Furthermore, recovery of SLC2A2 gene after 6-day insulin treatment also involves HNF-1alpha and HNF-3beta activity.


Assuntos
Transportador de Glucose Tipo 2/fisiologia , Fator 1-alfa Nuclear de Hepatócito/fisiologia , Fator 3-beta Nuclear de Hepatócito/fisiologia , Rim/metabolismo , Animais , Diabetes Mellitus/genética , Diabetes Mellitus/metabolismo , Ensaio de Desvio de Mobilidade Eletroforética , Regulação da Expressão Gênica/efeitos dos fármacos , Transportador de Glucose Tipo 2/genética , Transportador de Glucose Tipo 2/metabolismo , Insulina/farmacologia , Rim/efeitos dos fármacos , Masculino , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar
10.
Anim. Reprod. (Online) ; 6(2): 422-427, 2009. graf
Artigo em Inglês | VETINDEX | ID: biblio-1461597

RESUMO

The objective of this study was to evaluate the reproductive performance of ewes mated in the spring when given nutritional supplements to enhance energy levels. Ewes were assessed for weight and body condition at the beginning and end of flushing periods. Lambing rates and rates of proliferation were also evaluated. Crossbred woolly ewes (n = 46), 36 ± 2 months of age and rated 3.0 ± 0.1 on a body condition scale that spanned from 1 to 5 were divided into four treatment groups. One group received no feed supplements (NFS), while the others were supplemented for 64 days: 21 days before and 43 days during the mating season. The latter groups were fed soybean hulls at 0.6% (S06), 0.9% (S09) and 1.2% (S12) of their body weight (BW), calculated using dry mass. Ewes were mated for 50 days with four rams by means of natural breeding in October and November, which is spring in Brazil. There was no significant difference among the treatments based on mean BW of the ewes before and after the supplementation period (P > 0.05). Similarly, no differences were found in the rates of proliferation (P > 0.05). The S09 treatment presented the highest lambing rate (82%, 9/11), while the NFS treatment correlated with the lowest rate (42%, 5/12; P < 0.05). There was a positive linear effect for body condition score as the supplementation level increased (P < 0.05). We conclude that a supplementation level of 0.9% BW seems to improve lambing rates for ewes that undergo springtime mating.


Assuntos
Animais , Ciências da Nutrição , Fertilidade/fisiologia , Glycine max , Ovinos/classificação , Técnicas Reprodutivas
11.
Anim. Reprod. ; 6(2): 422-427, 2009. graf
Artigo em Inglês | VETINDEX | ID: vti-9399

RESUMO

The objective of this study was to evaluate the reproductive performance of ewes mated in the spring when given nutritional supplements to enhance energy levels. Ewes were assessed for weight and body condition at the beginning and end of flushing periods. Lambing rates and rates of proliferation were also evaluated. Crossbred woolly ewes (n = 46), 36 ± 2 months of age and rated 3.0 ± 0.1 on a body condition scale that spanned from 1 to 5 were divided into four treatment groups. One group received no feed supplements (NFS), while the others were supplemented for 64 days: 21 days before and 43 days during the mating season. The latter groups were fed soybean hulls at 0.6% (S06), 0.9% (S09) and 1.2% (S12) of their body weight (BW), calculated using dry mass. Ewes were mated for 50 days with four rams by means of natural breeding in October and November, which is spring in Brazil. There was no significant difference among the treatments based on mean BW of the ewes before and after the supplementation period (P > 0.05). Similarly, no differences were found in the rates of proliferation (P > 0.05). The S09 treatment presented the highest lambing rate (82%, 9/11), while the NFS treatment correlated with the lowest rate (42%, 5/12; P < 0.05). There was a positive linear effect for body condition score as the supplementation level increased (P < 0.05). We conclude that a supplementation level of 0.9% BW seems to improve lambing rates for ewes that undergo springtime mating.(AU)


Assuntos
Animais , Ciências da Nutrição , Glycine max , Fertilidade/fisiologia , Ovinos/classificação , Técnicas Reprodutivas
12.
Can J Physiol Pharmacol ; 77(4): 286-92, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10535677

RESUMO

The hypothalamic serotonergic system is involved in the regulation of food ingestion and energy metabolism. Since disturbances of both energy intake and expenditure can contribute to obesity, the objective of the present study was to evaluate the serotonergic response stimulated by food ingestion in two different models of obesity: the hyperphagic Zucker and the hypophagic and hypometabolic, monosodium glutamate (MSG) obese Wistar rat. For this we used microdialysis to examine the release of 5-hydroxytryptamine (serotonin, 5HT) and 5-hydroxyindoleacetic acid (5HIAA) in the lateral hypothalamus. Daily intake of MSG-obese rats was 40% lower while that of Zucker obese rats was 60% higher than that of the respective lean controls. In overnight-fasted animals, 20-min microdialysate samples were collected before (basal release) and during a 2-h period of access to a balanced palatable food mash. The animals began to eat during the first 20 min of food access, and food consumption was similar among the four groups in all six individual 20-min periods recorded. Ingestion of food increased 5HT release in all groups. In MSG-obese and lean Wistar rats, 5HT levels were similarly elevated during the whole experimental period. In the Zucker strain, 5HT increments of basal release tended to be higher in obese than in lean rats at 20 and 40 min, and a significantly higher increment was observed at 60 min after food access (40 and 135% for lean and obese, respectively). The area under the curve relating serotonin levels to the 120 min of food availability was significantly higher in Zucker obese (246.7 +/- 23.3) than MSG-obese (152.7 +/- 13.4), lean Wistar (151.9 +/- 11.1), and lean Zucker (173.5 +/- 24.0) rats. The present observation, of a food-induced serotonin release in the lateral hypothalamus of lean Wistar and Zucker rats, evidences that 5HT in the lateral hypothalamus is important in the normal response to feeding. In obese animals, the serotonin response was similar to (in the hypophagic-hypometabolic MSG model) or even higher than (in the hyperphagic Zucker model) that seen in the respective lean controls. This result indicates that the energy homeostasis disturbances of both these obesity models may not be ascribed to an impairment of the acute lateral hypothalamic serotonin response to a dietary stimulus.


Assuntos
Ingestão de Alimentos , Região Hipotalâmica Lateral/metabolismo , Microdiálise , Obesidade/metabolismo , Serotonina/metabolismo , Animais , Ácido Hidroxi-Indolacético/metabolismo , Masculino , Ratos , Ratos Wistar , Ratos Zucker , Glutamato de Sódio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA